Vascular Dysfunction and
Acute Pressure Syndromes

National Congress
Orlando, FL

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Intended Audience:

This symposium is designed for emergency medicine specialists, emergency medicine fellows, emergency medicine nurses, nurse practitioners (NPs) with EM concentration, physician assistants (PAs) with emergency medicine focus, prehospital care providers, cardiologists and cardiovascular specialists, critical care physicians and intensivists

Registration:

Enrollment for this webcast is complimentary, and clinicians are invited to attend this CME-certified symposium and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent educational grant from The Medicines Company, Inc.

Accreditation Statement for Jointly-Sponsored Programs:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Faculty Disclosures:

Christopher B. Granger, MD
Educational Grants and/or Research Support: Alexion, Astra Zeneca, Procter and Gamble, sanofi-aventis, Novartis, The Medicines Company, Boehringer Ingelheim, Genentech, and Berlex

James Ferguson III, MD, FACC
Grant/Research Support: Eisai, The Medicines Company, Viatron/Medtronic
Consultant: BMS, Eisai, Prism, Sanofi-Aventis, Schering Plough, Takeda, The Medicines Company., Therox
Speaker’s Bureau: BMS, Sanofi-Aventis, Schering Plough

Jerrold H. Levy, MD
Grant/Research Support: Alexion
Consultant: Bayer HealthCare, Dyax, Novo Nordisk, and Organon

Charles V. Pollack Jr, MA, MD, FACEP, FAAEM
Grant/Research Support: GlaxoSmithKline
Consultant: The Medicines Company., Schering-Plough, Sanofi-Aventis, BMS, Genentech, Speaker’s Bureau: Schering-Plough, Sanofi-Aventis, BMS, Genentech

Program Faculty:

Program Chairman
Christopher B. Granger, MD
Associate Professor
Department of Medicine
Division of Cardiology
Duke University Medical Center
Co-Director, Clinical Trials
Duke Clinical Research Institute (DCRI)
Durham, North Carolina

Distinguished Faculty
James Ferguson III, MD, FACC
Associate Director, Cardiology Research
Texas Heart Institute at St. Luke’s Episcopal
Hospital
Associate Professor
Baylor College of Medicine
Clinical Assistant Professor
University of Texas Health Science Center at
Houston
Houston, Texas

Jerrold H. Levy, MD
Professor and Deputy Chair for Research
Emory University School of Medicine
Director of Cardiothoracic Anesthesiology
Cardiothoracic Anesthesiology and Critical Care
Emory Healthcare
Atlanta, Georgia

Charles V. Pollack Jr, MS, MD, FACEP, FAAEM
Chairman, Department of Emergency Medicine
Pennsylvania Hospital
Professor of Emergency Medicine
University of Pennsylvania
School of Medicine
Philadelphia, Pennsylvania

Educational Objectives:

• Learn to identify underlying chronic, acute, and perioperative precipitants of acute elevations in systemic blood pressure and how this syndrome presents across multiple cardiovascular disease states and patient populations.
• Learn to assess and implement optimal pharmacologic interventions for patients presenting with manifestations of vascular dysfunction and acute pressure syndromes, including elevated systolic or diastolic blood pressure, end organ dysfunction, and other cardiovascular, renovascular, and/or neu­rovascular derangements.
• Learn to characterize, identify, and evaluate myriad, acute CV dis ease states producing serious and/or life-threatening elevations in systemic blood pressure, among them: hypertensive urgency,
  hypertensive crisis, ischemic stroke, drug-induced acute pres sure syndromes, subarachnoid hemorrhage, intracerebral hemorrhage, pulmonary edema, and related conditions.
• Learn to understand the specific advantages and poten tial disadvantages of currently available intravenously administered pharmacologic agents used to manage acute, serious, and/or life-threatening elevations in sys temic blood pressure.
• Learn to identify the ideal properties of intravenous agents used to provide cardiology-based lowering of potentially serious and/or life-threatening elevations in systemic blood pressure.
• Learn to discuss and assess the impact that new trials and novel agents are likely to have on future manage ment of patients with cardiovascular disease and acute pressure syndromes.
• Learn to apply national guidelines and expert, consensus-based recommendations in order to optimize therapy of pa tients with serious, systemic elevations in blood pressure.

Disclaimer:

Copyright © 2007 by Pharmatecture, LLC. All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this WebCAST reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this WebCAST is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this WebCAST is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This WebCAST is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This WebCAST is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright (c) 2007 All rights reserved